The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in TARDBP, which encodes the transactive response DNA binding protein 43 kDa (TDP-43), are the third most common cause of familial autosomal dominant ALS and account for rare cases of sporadic ALS [290–293].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [291]
In the citing paper
“while mutations in TARDBP (encoding TAR DNA- binding protein 43 [TDP43])306 and FUS (encoding the fused in sarcoma protein) have a lower frequency (<5%).307”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“emphasizing that microglia in the late stage accelerate disease progression.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“and mutations in TARDBP, the gene encoding TDP-43, have been identified in patients with ALS or FTD,306,333 indicating a mechanistic link between TDP-43 and ALS/FTD and also suggesting a common underlying mechanism”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“Reduced mutant levels in microglia did not have much effect on early disease progression, but substantially slowed it later on,306”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. R., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-166 · Cited by 676
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Self-citationTDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S. G., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 474
Self-citationCo-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468
Cited by
Sorted by citations
Items 701–800 of 1,011
Ling, S., Dastidar, S. G., Tokunaga, S., Ho, W. Y., Lim, K., Ilieva, H. S., Parone, P. A., Tyan, S.-H., Tse, T. M., Chang, J., et al. (2019) · eLife · doi:10.7554/elife.40811 · Cited by 87
Self-citationTDP-43 plasma levels are higher in amyotrophic lateral sclerosis
Verstraete, E., Kuiperij, H. B., van Blitterswijk, M., Veldink, J. H., Schelhaas, H. J., van den Berg, L. H., & Verbeek, M. M. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2012.703208 · Cited by 86
Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 86
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
Hayes, L. R., & Kaláb, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01260-5 · Cited by 86
Redox Regulation in Amyotrophic Lateral Sclerosis
Parakh, S., Spencer, D. M. S., Halloran, M. A., Soo, K. Y., & Atkin, J. D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/408681 · Cited by 85
The small heat shock proteins αB-crystallin and Hsp27 suppress SOD1 aggregation in vitro
Yerbury, J. J., Gower, D., Vanags, L. Z., Roberts, K., Lee, J., & Ecroyd, H. W. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0371-1 · Cited by 85
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population
Sabatelli, M., Conforti, F. L., Zollino, M., Mora, G., Monsurrò, M. R., Volanti, P., Marinou, K., Salvi, F., Corbo, M., Giannini, F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.011 · Cited by 84
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 84
Yamashita, T., & Kwak, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.011 · Cited by 84
Armstrong, G. A. B., & Drapeau, P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4003-12.2013 · Cited by 84
Ma, L., Zhao, Y., Chen, Y., Cheng, B., Peng, A., & Huang, K. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.051 · Cited by 84
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
Jeon, G. S., Shim, Y., Lee, D., Kim, J.-S., Kang, M., Ahn, S. H., Shin, J.-Y., Geum, D., Hong, Y., & Sung, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1218-2 · Cited by 84
Hortobágyi, T., Troakes, C., Nishimura, A. L., Vance, C. A., Swieten, J. C. V., Seelaar, H., King, A., Al‐Sarraj, S., Rogelj, B., & Shaw, C. E. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0813-3 · Cited by 83
Self-citationBlood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
Robelin, L., & de Aguilar, J. G. (2014) · BioMed Research International · doi:10.1155/2014/525097 · Cited by 83
Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease
Jinn, S., Blauwendraat, C., Toolan, D. M., Gretzula, C. A., Drolet, R. E., Smith, S., Nalls, M. A., Marcus, J., Singleton, A., & Stone, D. J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz136 · Cited by 83
Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not
Hardy, J., & Rogaeva, E. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.006 · Cited by 83
Teuling, E., van Dis, V., Wulf, P. S., Haasdijk, E. D., Akhmanova, A. S., Hoogenraad, C. C., & Jaarsma, D. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn182 · Cited by 83
FUS and TDP43 genetic variability in FTD and CBS
Huey, E. D., Ferrari, R., Moreno, J. H., Jensen, C., Morris, C. M., Potocnik, F., Kalaria, R. N., Tierney, M., Wassermann, E. M., Hardy, J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.004 · Cited by 82
“All 15 exons of FUS and all 6 exons of TDP-43 were sequenced as previously described (Sreedharan et al., 2008; Vance et al., 2009).”
BackgroundMethodVelebit, J., Horvat, A., Smolič, T., Mihevc, S. P., Rogelj, B., Zorec, R., & Vardjan, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-62864-5 · Cited by 82
Self-citationTDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons
Nagano, S., Jinno, J., Abdelhamid, R. F., Jin, Y., Shibata, M., Watanabe, S., Hirokawa, S., Nishizawa, M., Sakimura, K., Onodera, O., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02205-y · Cited by 82
Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
Guo, D., Liu, Z., Zhou, J., Ke, C., & Li, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189947 · Cited by 83
Shi, P., Wei, Y., Zhang, J. Y., Gál, J., & Zhu, H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100366 · Cited by 82
RNA-binding proteins in neurological diseases
Zhou, H.-L., Mangelsdorf, M., Liu, J., Zhu, L., & Wu, J. Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4647-9 · Cited by 82
Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control
Palomo, G. M., & Manfredi, G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.065 · Cited by 81
FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS
Tsai, C.-P., Soong, B., Lin, K., Tu, P., Lin, J.-L., & Lee, Y. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.009 · Cited by 81
Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery
Planell-Saguer, M. D., Schroeder, D. G., Rodicio, M. C., Cox, G. A., & Mourelatos, Z. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp134 · Cited by 81
RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy
Ihara, R., Matsukawa, K., Nagata, Y., Kunugi, H., Tsuji, S., Chihara, T., Kuranaga, E., Miura, M., Wakabayashi, T., Hashimoto, T., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt296 · Cited by 81
A de novo missense mutation of the FUS gene in a “true” sporadic ALS case
Chiò, A., Calvo, A., Moglia, C., Ossola, I., Brunetti, M., Sbaiz, L., Lai, S.-L., Abramzon, Y. A., Traynor, B. J., & Restagno, G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.016 · Cited by 81
Fung, G., Shi, J., Deng, H., Hou, J., Wang, C., Hong, A., Zhang, J.-Q., Jia, W. W.-G., & Luo, H. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.58 · Cited by 81
Bishof, I., Dammer, E. B., Duong, D. M., Kundinger, S. R., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001747 · Cited by 80
From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis
Grad, L. I., Fernando, S. M., & Cashman, N. R. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.009 · Cited by 80
Maurel, C., Dangoumau, A., Marouillat, S., Brulard, C., Chami, A. A., Hergesheimer, R. C., Corcia, P., Blasco, H., Andres, C. R., & Vourc’h, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0856-0 · Cited by 82
TDP-43 pathology: From noxious assembly to therapeutic removal
Keating, S. S., Gil, R. S., Swanson, M. E. V., Scotter, E. L., & Walker, A. K. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102229 · Cited by 81
Ambegaokar, S. S., Roy, B., & Jackson, G. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.026 · Cited by 80
Aberrant RNA processing events in neurological disorders
Anthony, K., & Gallo, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.008 · Cited by 80
Sasayama, H., Shimamura, M., Tokuda, T., Azuma, Y., Yoshida, T., Mizuno, T., Nakagawa, M., Fujikake, N., Nagai, Y., & Yamaguchi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039483 · Cited by 80
Dynamics of axonal mRNA transport and implications for peripheral nerve regeneration
Yoo, S., van Niekerk, E. A., Merianda, T. T., & Twiss, J. L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.011 · Cited by 80
The molecular basis of frontotemporal dementia
Neumann, M., Tolnay, M., & Mackenzie, I. R. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001136 · Cited by 80
Suárez‐Calvet, M., Dols‐Icardo, O., Lladó, A., Sánchez‐Valle, R., Hernandez, I., Amer, G., Antón‐Aguirre, S., Alcolea, D. A., Fortea, J., Ferrer, I., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305972 · Cited by 80
RNA metabolism and the pathogenesis of motor neuron diseases
Lemmens, R., Moore, M. J., Al‐Chalabi, A., Brown, R. H., & Robberecht, W. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.02.003 · Cited by 80
Self-citationSchoen, M., Reichel, J. M., Demestre, M., Putz, S., Deshpande, D., Proepper, C., Liebau, S., Schmeißer, M. J., Ludolph, A. C., Michaelis, J., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00496 · Cited by 80
Yaron, A., & Schuldiner, O. (2016) · Current Biology · doi:10.1016/j.cub.2016.05.025 · Cited by 81
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients
Perrone, F., Nguyen, H. P., Mossevelde, S. V., Moisse, M., Sieben, A., Santens, P., Bleecker, J. D., Vandenbulcke, M., Engelborghs, S., Baets, J., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.008 · Cited by 80
TDP-43 suppresses tau expression via promoting its mRNA instability
Gu, J., Wu, F., Xu, W., Shi, J., Hu, W. H., Jin, N., Qian, W., Wang, X., Iqbal, K., Gong, C., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx175 · Cited by 80
Boehringer, A. V., Garcia‐Mansfield, K., Singh, G. M., Bakkar, N., Pirrotte, P., & Bowser, R. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-14924-6 · Cited by 80
Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis
Fogarty, M. J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.023 · Cited by 80
Proudfoot, M. J., Gutowski, N. J., Edbauer, D., Hilton, D. A., Stephens, M., Rankin, J., & Mackenzie, I. R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1245-7 · Cited by 79
Nitta, Y., & Sugie, A. (2022) · Fly · doi:10.1080/19336934.2022.2087484 · Cited by 81
TDP ‐43 associates with stalled ribosomes and contributes to cell survival during cellular stress
Higashi, S., Kabuta, T., Nagai, Y., Tsuchiya, Y., Akiyama, H., & Wada, K. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12194 · Cited by 79
van der Graaff, M. M., de Jong, J. M. B. V., Baas, F., & de Visser, M. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.10.002 · Cited by 79
Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Goutman, S. A. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000535 · Cited by 79
van Es, M. A., Dahlberg, C., Birve, A., Veldink, J. H., van den Berg, L. H., & Andersen, P. M. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.181453 · Cited by 78
Oral, Ö., Akkoç, Y., Bayraktar, O., & Gözüaçık, D. (2016) · PubMed · doi:10.14670/hh-11-714 · Cited by 78
BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain
Pourhaghighi, M. R., Ash, P. E. A., Phanse, S., Goebels, F., Hu, L. Z., Chen, S., Zhang, Y., Wierbowski, S. D., Boudeau, S., Moutaoufik, M. T., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2020.03.003 · Cited by 79
Tardiff, D. F., Tucci, M. L., Caldwell, K. A., Caldwell, G. A., & Lindquist, S. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308668 · Cited by 78
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS
Ito, D., & Suzuki, N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343365 · Cited by 78
Estes, P. S., Daniel, S. G., McCallum, A. P., Boehringer, A. V., Sukhina, A. S., Zwick, R. A., & Zarnescu, D. C. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010710 · Cited by 78
Shiihashi, G., Ito, D., Yagi, T., Nihei, Y., Ebine, T., & Suzuki, N. (2016) · Brain · doi:10.1093/brain/aww161 · Cited by 78
MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis
Wu, C., Watts, M. E., & Rubin, L. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.019 · Cited by 78
Lunn, J. S., Sakowski, S. A., & Feldman, E. L. (2014) · Stem Cells · doi:10.1002/stem.1628 · Cited by 77
Carra, S., Crippa, V., Rusmini, P., Boncoraglio, A., Minoia, M., Giorgetti, E., Kampinga, H. H., & Poletti, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.009 · Cited by 77
Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration
Robinson, J. L., Porta, S., Garrett, F. G., Zhang, P., Xie, S. X., Suh, E. R., Deerlin, V. M. V., Abner, E. L., Jicha, G. A., Barber, J. M., et al. (2020) · Brain · doi:10.1093/brain/awaa219 · Cited by 77
The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
Rengifo-Gonzalez, J. C., Hage, K. E., Clément, M., Steiner, E., Joshi, V., Craveur, P., Christiane, D. D., Pastré, D., & Bouhss, A. (2021) · eLife · doi:10.7554/elife.67605 · Cited by 77
Gribkoff, V. K., & Bozik, M. E. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00048.x · Cited by 77
Cdc37/Hsp90 Protein Complex Disruption Triggers an Autophagic Clearance Cascade for TDP-43 Protein
Jinwal, U. K., Abisambra, J. F., Zhang, J., Dharia, S. P., O’Leary, J. C., Patel, T., Braswell, K., Jani, T., Gestwicki, J. E., & Dickey, C. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367268 · Cited by 77
Haase, G., & Rabouille, C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00448 · Cited by 78
Kitamura, A., Nakayama, Y., Shibasaki, A., Taki, A., Yuno, S., Takeda, K., Yahara, M., Tanabe, N., & Kinjo, M. (2016) · Scientific Reports · doi:10.1038/srep19230 · Cited by 77
The genotype–phenotype landscape of familial amyotrophic lateral sclerosis in Australia
McCann, E. P., Williams, K. L., Fifita, J. A., Tarr, I. S., O'Connor, J. J., Rowe, D. B., Nicholson, G. A., & Blair, I. P. (2017) · Clinical Genetics · doi:10.1111/cge.12973 · Cited by 77
Self-citationThe neuropathological signature of bulbar-onset ALS: A systematic review
Shellikeri, S., Karthikeyan, V., Martino, R., Black, S. E., Zinman, L. H., Keith, J. L., & Yunusova, Y. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.045 · Cited by 77
Chand, K. K., Lee, K. M., Lee, J. D., Qiu, H., Willis, E. F., Lavidis, N. A., Hilliard, M. A., & Noakes, P. G. (2018) · The FASEB Journal · doi:10.1096/fj.201700835r · Cited by 78
Peng, A. Y. T., Agrawal, I., Ho, W. Y., Yen, Y.-C., Pinter, A. J., Liu, J., Phua, Q. X. C., Koh, K. B., Chang, J., Sanford, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007806117 · Cited by 77
George‐Hyslop, P. S., Lin, J. Q., Miyashita, A., Phillips, E. C., Qamar, S., Randle, S. J., & Wang, G. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.036 · Cited by 76
Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration
Gendron, T. F., Josephs, K. A., & Petrucelli, L. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01060.x · Cited by 76
Shahidullah, M., Marchand, S. J. L., Hong, F., Zhang, J., Pandey, U. B., Dalva, M. B., Pasinelli, P., & Levitan, I. B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3396-13.2013 · Cited by 76
Yap, K., & Makeyev, E. V. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.01.003 · Cited by 77
Recent advances in motor neuron disease
Damme, P. V., & Robberecht, W. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832ffbe3 · Cited by 76
PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43
Joardar, A., Menzl, J., Podolsky, T. C., Manzo, E., Estes, P. S., Ashford, S., & Zarnescu, D. C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu587 · Cited by 76
The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis
Nonneman, A., Robberecht, W., & Bosch, L. V. D. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.21 · Cited by 76
Molecular Genetics of Neurodegenerative DementiasPreprint
Hinz, F. I., & Geschwind, D. H. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023705 · Cited by 76
Renoux, A. J., & Todd, P. K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.006 · Cited by 75
Thomas, M., Alegre‐Abarrategui, J., & Wade‐Martins, R. (2013) · Brain · doi:10.1093/brain/awt030 · Cited by 75
Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis
Roczniak-Ferguson, A., & Ferguson, S. M. (2019) · Life Science Alliance · doi:10.26508/lsa.201900358 · Cited by 75
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Ludolph, A. C., Dupuis, L., Kasarskis, E. J., Steyn, F. J., Ngo, S. T., & McDermott, C. J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00845-8 · Cited by 75
Oiwa, K., Watanabe, S., Onodera, K., Iguchi, Y., Kinoshita, Y., Komine, O., Sobue, A., Okada, Y., Katsuno, M., & Yamanaka, K. (2023) · Science Advances · doi:10.1126/sciadv.adf6895 · Cited by 75
β-Amyloid triggers ALS-associated TDP-43 pathology in AD models
Herman, A. M., Khandelwal, P. J., Stanczyk, B. B., Rebeck, G. W., & Moussa, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.052 · Cited by 75
Caenorhabditis elegans RNA-processing Protein TDP-1 Regulates Protein Homeostasis and Life Span
Zhāng, T., Hwang, H., Hao, H., Talbot, C. C., & Wang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311977 · Cited by 75
Waibel, S., Neumann, M., Rosenbohm, A., Birve, A., Volk, A. E., Weishaupt, J. H., Meyer, T., Müller, U., Andersen, P. M., & Ludolph, A. C. (2012) · European Journal of Neurology · doi:10.1111/ene.12031 · Cited by 75
Che, M., Jiang, Y., Xie, Y., Jiang, L., & Hu, H. (2011) · The FASEB Journal · doi:10.1096/fj.10-174482 · Cited by 75
FUS Mutations in Familial Amyotrophic Lateral Sclerosis in the Netherlands
Groen, E. J. N., van Es, M. A., van Vught, P. W. J., Spliet, W. G. M., Engelen-Lee, J.-Y., de Visser, M., Wokke, J. H. J., Schelhaas, H. J., Ophoff, R. A., Fumoto, K., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.329 · Cited by 75
Ubiquitin receptors and protein quality control
Wang, X., & Terpstra, E. J. M. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.012 · Cited by 75
Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74
ALS and frontotemporal dysfunction: a review
Achi, E. Y., & Rudnicki, S. A. (2012) · Neurology Research International · doi:10.1155/2012/806306 · Cited by 74
Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
Chen, H., Kankel, M. W., Su, S. C., Han, S., & Ofengeim, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0060-4 · Cited by 74
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Tarutani, A., Adachi, T., Akatsu, H., Hashizume, Y., Hasegawa, K., Saito, Y., Robinson, A., Mann, D. M. A., Yoshida, M., Murayama, S., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02426-3 · Cited by 74
Update on recent advances in amyotrophic lateral sclerosis
Riva, N., Domi, T., Pozzi, L., Lunetta, C., Schito, P., Spinelli, E. G., Cabras, S., Matteoni, E., Consonni, M., Bella, E. D., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12435-9 · Cited by 74
Endoplasmic reticulum stress and the ER mitochondria calcium cycle in amyotrophic lateral sclerosis
Lautenschläger, J., Prell, T., & Großkreutz, J. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.641569 · Cited by 74
SOD1 and mitochondria in ALS: a dangerous liaison
Carrı̀, M. T., & Cozzolino, M. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9394-z · Cited by 74
Parkinsonism and motor neuron diseases: Twenty‐seven patients with diverse overlap syndromes
Gilbert, R., Fahn, S., Mitsumoto, H., & Rowland, L. P. (2010) · Movement Disorders · doi:10.1002/mds.23200 · Cited by 74
Sundaramoorthy, V., Sultana, J. M., & Atkin, J. D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00400 · Cited by 74
Metadata
- Authors
- Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C., Nicholson, G., & Shaw, C. E.
- Affiliations
- The University of Sydney (AU)
- Department of Clinical Neuroscience, King's College London, Medical Research Council (MRC) Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
- Corresponding author
- Sreedharan, Jemeen
- Blair, Ian P.
- Tripathi, Vineeta B.
- Nicholson, Garth
- Shaw, Christopher E.
- ORCID
- Venue
- Science
- Published
- 2008-03-21
- Volume
- 319
- Issue
- 5870
- Pages
- 1668-1672
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7116650
- OpenAlex
- W1619082318
- Cited by
- 2,630
- References
- 29
- Citations by year
- 2026: 73 · 2025: 88 · 2024: 104 · 2023: 141 · 2022: 149 · 2021: 141 · 2020: 149 · 2019: 121 · 2018: 147 · 2017: 117 · 2016: 156 · 2015: 154 · 2014: 167 · 2013: 168 · 2012: 192
- FWCI
- 119.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- Wellcome Trust (076671)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, TDP-43, TARDBP, familial ALS, sporadic ALS, TDP-43 mutations, chromosome 1p36, genetic linkage, ubiquitinated inclusions, neurodegeneration, neuronal apoptosis, protein fragmentation
- MeSH terms
- Adult, Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Chick Embryo, Chromosomes, Human, Pair 1, Cricetulus, DNA-Binding Proteins, Female, Cricetinae, Humans, Male, Middle Aged, Molecular Sequence Data, Neurons, CHO Cells, Apoptosis, Microsatellite Repeats, Amino Acid Substitution, Mutation, Missense, Embryonic Development, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review